Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7
Closed 622
2022
Q1
$0 Sell
7
-104
-94% -$4.47K ﹤0.01% 629
2021
Q4
$5K Buy
111
+79
+247% +$3.54K ﹤0.01% 563
2021
Q3
$1.33K Hold
32
﹤0.01% 1164
2021
Q2
$1.45K Hold
32
﹤0.01% 1158
2021
Q1
$1.41K Sell
32
-8
-20% -$302 ﹤0.01% 1107
2020
Q4
$1.39K Hold
40
﹤0.01% 1068
2020
Q3
$693 Hold
40
﹤0.01% 1040
2020
Q2
$657 Hold
40
﹤0.01% 1011
2020
Q1
$363 Sell
40
-6
-13% -$121 ﹤0.01% 1001
2019
Q4
$978 Hold
46
﹤0.01% 993
2019
Q3
$1.06K Hold
46
﹤0.01% 990
2019
Q2
$1.12K Buy
46
+8
+21% +$165 ﹤0.01% 1007
2019
Q1
$492 Sell
38
-16
-30% -$280 ﹤0.01% 1042
2018
Q4
$813 Sell
54
-81
-60% -$2.1K ﹤0.01% 1031
2018
Q3
$5.31K Hold
135
﹤0.01% 951
2018
Q2
$6.64K Sell
135
-100
-43% -$5.67K ﹤0.01% 925
2018
Q1
$14K Hold
235
﹤0.01% 749
2017
Q4
$18.5K Sell
235
-23
-9% -$1.85K ﹤0.01% 697
2017
Q3
$21.7K Buy
+258
New +$18.3K ﹤0.01% 658

Other funds holding ADNT

RBC Europe's ADNT Position: Q2 2022 in Review

RBC Europe sold out of Adient (ADNT) in Q2 2022, closing a stake of 7 shares.

RBC Europe first reported a position in ADNT in Q3 2017 and held it in 19 quarters. The position peaked at $21.7K in Q3 2017. 258 funds tracked by Wall St. Rank hold ADNT as of Q2 2022.

  • RBC Europe reported no remaining Adient position as of Q2 2022 after selling out during the quarter.
  • RBC Europe sold 7 Adient shares in Q2 2022.
  • RBC Europe first reported a position in Adient in Q3 2017 and held it in 19 quarters.
  • RBC Europe's Adient position peaked at $21.7K in Q3 2017.
  • 258 funds tracked by Wall St. Rank held Adient as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.